Post Profile






Researchers discover resistance mechanism to checkpoint inhibitors and how to reverse it

(European Society for Medical Oncology) Researchers have discovered a mechanism of resistance to checkpoint inhibitors and how to reverse it. The biomarker results from the IMvigor210 study are reported at the ESMO Immuno Oncology Congress 2017.
read more

share

Related Posts


Neoadjuvant immunotherapy prior to surgery is safe and feasible in early lung cancer

Health : EurekAlert: Health

(European Society for Medical Oncology) Neoadjuvant immunotherapy with the PD-1 inhibitor nivolumab is safe and feasible prior to surgery for early lung cancer, researchers reported at the ESMO 2016 Congress in Copenhagen.

Biothera To Present Research Results At European Society For Medical Oncology World Gastrointestinal Congress

Health : Medical News Today

Biothera has been accepted to present data from its Phase II clinical trial in stage IV KRAS-mutant colorectal cancer at the European Society for Medical Oncology (ESMO) 13th World Congress on Gastrointestinal Cancer June 22-25 in B...

ESMO Asia 2017 Congress

Health : EurekAlert: Health

(European Society for Medical Oncology) The European Society for Medical Oncology (ESMO), the leading professional organisation for medical oncology, is pleased to announce the third ESMO Asia 2017 Congress (1).

Novel compound restores immune response in patients with melanoma

Health : EurekAlert: Health

(European Society for Medical Oncology) A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017.

Sneak peek into the ESMO 2017 press program

Health : EurekAlert: Health

(European Society for Medical Oncology) ESMO 2017 is once again the place to be for breaking news on cancer research. ESMO 2017, the annual oncology congress organized by the European Society for Medical Oncology (ESMO) in partnersh...

Comments


Copyright © 2016 Regator, LLC